The U.S. Food and Drug Administration (FDA) announced that it would change the emergency contraceptive pill's, Plan B's, labeling.
In a memo released on Friday, the agency said it would remove wording about fertilization and implantation from the pill’s packaging.
Officials cited scientific evidence that the pill prevents pregnancy by acting on ovulation, which occurs before implantation, and has no direct effect on fertilization or implantation.
“Evidence does not support that the drug affects implantation or maintenance of a pregnancy after implantation, therefore it does not terminate a pregnancy,” the FDA said.
After Roe v. Wade, a landmark ruling that protected the right to abortion on a federal level, was overturned in June, abortion is now banned in at least 13 U.S. states. Following the decision, Supreme Court Justice Clarence Thomas hinted that contraception could be next.
Plan B pill One-Step and its generic equivalents are taken after the usual contraception method fails or after unprotected sex. Currently, this over-the-counter drug is available in all U.S. states.
According to the American College of Obstetricians and Gynecologists, the pill “is unlikely to prevent implantation of a fertilized egg.”
The Centers for Disease Control and Prevention (CDC) data shows that among women aged 22–49 years who have ever had sexual intercourse, 24.3% have ever used emergency contraception.